AI develops cancer treatment in 30 days, predicts survival rate | New York Post
Artificial intelligence has developed a treatment for cancer in just 30 days and can predict a patient’s survival rate.
In a new study published in the journal Chemical Science, researchers at the University of Toronto along with Insilico Medicine developed a potential treatment for hepatocellular carcinoma (HCC) with an AI drug discovery platform called Pharma.AI.
HCC is the most common type of liver cancer and occurs when a tumor grows on the liver, according to Cleveland Clinic.
Researchers applied AlphaFold, an AI-powered protein structure database, to Pharma.AI to uncover a novel target — a previously unknown treatment pathway — for cancer and developed a “novel hit molecule” that could bind to that target without aid.
The creation of the potential drug was accomplished in just 30 days from the selection of the target and after synthesizing just seven compounds.
Read more at https://nypost.com/2023/03/20/....ai-develops-cancer-t
#cancer #ai #science #technology #artificialintelligence #health
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Subscribe to New York Post Sports: https://www.youtube.com/c/nypostsports
Catch the latest news here: https://nypost.com/
Follow The New York Post on:
Twitter - https://twitter.com/nypost
Facebook - https://www.facebook.com/NYPost
-
Category
No comments found